HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM (HeatShock)
This study is ongoing, but not recruiting participants.
Sponsor:
University of California, San Francisco
Collaborator:
Agenus, Inc.
Information provided by (Responsible Party):
Andrew Parsa, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00905060
First received: May 18, 2009
Last updated: May 14, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |